Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions.

Abstract

Fatty-acid amide hydrolase (FAAH) catalyzes the intracellular hydrolysis of the endocannabinoid anandamide and other bioactive lipid amides. In the present study, we conducted a comparative characterization of the effects of the newly identified brain-impermeant FAAH inhibitor, URB937 ([3-(3-carbamoylphenyl)-4-hydroxy-phenyl] N-cyclohexylcarbamate), in various rodent models of acute and persistent pain. When administered by the oral route in mice, URB937 was highly active (median effective dose, ED(50), to inhibit liver FAAH activity: 0.3mgkg(-1)) and had a bioavailability of 5.3%. The antinociceptive effects of oral URB937 were investigated in mouse models of acute inflammation (carrageenan), peripheral nerve injury (chronic sciatic nerve ligation) and arthritis (complete Freund's adjuvant). In all models, URB937 was as effective or more effective than standard analgesic and anti-inflammatory drugs (indomethacin, gabapentin, dexamethasone) and reversed pain-related responses (mechanical hyperalgesia, thermal hyperalgesia, and mechanical allodynia) in a dose-dependent manner. ED(50) values ranged from 0.2 to 10mgkg(-1), depending on model and readout. Importantly, URB937 was significantly more effective than two global FAAH inhibitors, URB597 and PF-04457845, in the complete Freund's adjuvant model. The effects of a combination of URB937 with the non-steroidal anti-inflammatory agent, indomethacin, were examined in the carrageenan and chronic sciatic nerve ligation models. Isobolographic analyses showed that the two compounds interacted synergistically to attenuate pain-related behaviors. Furthermore, URB937 reduced the number and severity of gastric lesions produced by indomethacin, while exerting no ulcerogenic effect when administered alone. The results indicate that the peripheral FAAH inhibitor URB937 is more effective than globally active FAAH inhibitors at inhibiting inflammatory pain. Our findings further suggest that FAAH and cyclooxygenase inhibitors interact functionally in peripheral tissues, to either enhance or hinder each other's actions.

• Authors: Oscar Sasso, Rosalia Bertorelli, Tiziano Bandiera, Rita Scarpelli, Giampiero Colombano, Andrea Armirotti, Guillermo Moreno-Sanz, Angelo Reggiani, Daniele Piomelli
• Journal: Pharmacological research (Pharmacol Res) Vol. 65 Issue 5 Pg. 553-63 (May 2012) ISSN: 1096-1186 [Electronic] Netherlands
• PMID: 22420940 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: Copyright © 2012 Elsevier Ltd. All rights reserved.

Chemical References

• Analgesics
• Anti-Inflammatory Agents, Non-Steroidal
• Benzamides
• Cannabinoids
• Carbamates
• Enzyme Inhibitors
• N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide
• Pyridazines
• URB937
• cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester
• Urea
• Amidohydrolases
• fatty-acid amide hydrolase
• Indomethacin

Topics

• Amidohydrolases (antagonists & inhibitors)
• Analgesics (administration & dosage, pharmacokinetics, pharmacology)
• Animals
• Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, toxicity)
• Arthritis, Experimental (drug therapy, physiopathology)
• Benzamides (pharmacology)
• Cannabinoids (administration & dosage, pharmacokinetics, pharmacology)
• Carbamates (pharmacology)
• Disease Models, Animal
• Enzyme Inhibitors (administration & dosage, pharmacokinetics, pharmacology)
• Hyperalgesia (drug therapy, physiopathology)
• Indomethacin (administration & dosage, toxicity)
• Male
• Mice
• Pain (drug therapy, physiopathology)
• Pyridazines (pharmacology)
• Sciatic Nerve (injuries, physiopathology)
• Stomach Ulcer (chemically induced, physiopathology, prevention & control)
• Urea (analogs & derivatives, pharmacology)